Home › Migraine › Minnesota › Minneapolis
Migraine clinical trials in Minneapolis, MN
4 studies for Migraine are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
RecruitingPhase 1
- Clinical Research Institute, Minneapolis
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
RecruitingPhase 3
- Clinical Research Institute, Minneapolis
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Clinical Research Institute, Minneapolis
Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli
RecruitingHealthy volunteers welcome
- University of Minnesota, Minneapolis
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Philadelphia, PA8 studies
- Concord, CA8 studies
- Amherst, NY7 studies
- Omaha, NE7 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- Stamford, CT6 studies
- San Diego, CA6 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.